European Gen Z and Millennials are more likely to consider GLP-1 medications than older gens. According to a new consumer report by BCG, one in four consumers across 11 European countries say they either use or are strongly considering using appetite suppressing medications like Ozempic, Wegovy, and Mounjaro. Among Gen Z and Millennials, 19% are considering these medications, and that number drops to just 8% among Gen X and Baby Boomers. For two gens that spend the most time online, these stats are not all so surprising. YPulse’s 2025 Health and Fitness report showed that the desire to lose weight has risen among young Europeans, especially due in part to #SkinnyTok and other similar trends on social media. However, our data also shows very few Gen Z and Millennials are trying these drugs. (BCG)
👀 Read more from YPulse: The Rise and Fall of #SkinnyTok on The Viral List
